View Full Version : General Cancer News
- Alpha-fetoprotein, a well-tolerated agent for treatment and prevention of breast canc
- SBI urges Congress to exclude the USPSTF guidelines from health care legislation
- Report on the latest innovations in oncology diagnostics market
- 'Suicide gene E' reduces potent drug dosage in cancer patients
- Senate Health Committee likely to hold hearing on new mammogram guidelines
- Aegis Breast 3.0 that offers powerful real-time 4D image processing to be launched
- Rising incidence of breast cancer driving the worldwide market for mammography equipm
- Three high risk indicators that aid mammography screening
- Breast Cancer Campaign awards a three year project grant to Cambridge scientist
- Study on response to breast cancer radiotherapy
- Study on deaths from cancer in Europe shows steady decline in mortality
- Siemens Healthcare to introduce high-end imaging systems for interventional oncologic
- Elastography decreases breast biopsies and maps tumors more precisely
- Charity urges government to stop under 18s from using sunbeds
- Minerva Biotechnologies grants Clarient exclusive commercializing rights to its MUC1*
- Presentations at Tuesday's RSNA conference
- Medipattern, Sentinelle Medical sign technology access and distribution agreement
- Sentinelle Medical's Aegis Navigation MRI and ultrasound imaging system showcased at
- Sentinelle Medical, Ultrasonix Medical announce distribution partnership for new Soni
- Don't Pause, a completely natural treatment to get rid of menopause symptoms
- BSGI proves to be an effective adjunct imaging modality for detecting DCIS
- Low-income women experience significantly greater gaps in access to health care
- Low-dose radiation increases breast cancer risk in high-risk women
- Researchers devise a way to deliver right therapy directly to tumors using aptamers
- Portuguese scientists identify a molecular mechanism that can lead to metastases in b
- MAbs for early detection of cancer
- Use of BSGI as adjunct imaging modality for diagnosing breast cancer demonstrated
- Cancer patient's chances of surviving for at least a year varies depending on where t
- U-Systems announces significant upgrade for somo•v ABUS at RSNA 2009
- New figures show steady decline in European cancer deaths, but variations exist betwe
- Positive data from Provectus Pharmaceuticals' psoriasis and atopic dermatitis trials
- Sentinelle Medical showcases its new line of breast MRI coils at the RSNA meeting
- Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02
- Imaging Diagnostic Systems showcases its CTLM system at the 2009 RSNA meeting
- Annual screening ultrasound may benefit women who are at elevated risk for breast can
- New data on pixantrone Phase III trial in non-Hodgkin's lymphoma to be presented
- TGF--1 suppresses the growth of cancer cells, find researchers
- Researchers develop new application for improved detection of breast cancer cells
- Boehringer Ingelheim to announce positive results from its RE-COVER study
- Cancer Prevention Research Conference highlights new research on cancer
- Protein ERK oscillates between two major compartments in breast tissue cells
- New data demonstrating the strength of Novartis' hematology portfolio to be presented
- RSNA: Dec. 2, 2009 briefing and presentations
- Coding guidelines for Agendia's MammaPrint test established by Palmetto GBA
- Women at high risk of developing breast cancer reluctant to take tamoxifen for preven
- Senators consider women's insurance amendment, Medicare funding issues, with votes li
- Novel approach to detect flaws in defense against breast cancer earns Era of Hope Sch
- Exposure to secondhand smoke may increase breast cancer risk
- Breast Cancer Fund: Congress must enforce BPA ban in food and beverage containers
- ImmunoCellular Therapeutics options immunotherapy targeting CSCs using abnormal Notch
- Macular Health eye vitamin supplement improves visual acuity
- Update on Celsion's ThermoDox Phase III “HEAT” trial for HCC
- At House hearing, panel seeks to clarify advice on mammograms
- BJOC dx timing links
- MRI "Omniscan" contrast under scrutiny
- Senate approves women's screening amendment in first health bill vote
- Alkermes licenses Medifusion technology to develop TNF receptor-Fc fusion protein
- Multi-Lumen MammoSite device to treat breast cancer now available at Jupiter Medical
- Protein plays a key role in cancer and DNA repair
- Pfizer announces a $9M cancer research collaboration in British Columbia
- NCCC's study data on passive smoking and breast cancer in women
- Health leaders to discuss latest breast cancer findings at CTRC-AACR San Antonio Brea
- Controversy over recent breast cancer screening guidelines discussed
- FUJIFILM to interface Raytheon BBN Technologies' SDM technology with its Aspire HD FF
- Pfizer to present study findings from its expanded breast cancer portfolio
- Senate bill moves forward, amendment ensures coverage for women's preventive care
- Thermography, an ideal screening tool for breast cancer
- 'Twist' gene plays a key role in the development of breast cancer
- Patients new to chronic disease medication face risk of medication discontinuation, f
- Genomic Health to present its Oncotype DX multi-gene expression test studies at the 3
- World records and fight against breast cancer fundraiser
- Temp agencies harbor unfit nurses?
- Dabigatran etexilate offers effective therapy to prevent recurrent VTE
- FDA approves new technology tool for breast cancer screening
- TGFb growth factor controls spread of cancer cells
- Updated results from pivotal phase III EXTEND clinical trial of pixantrone announced
- SU2C awards $9.68 million to support high-risk/high-reward cancer research
- Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin
- Black women may need different mammogram guidelines
- Celldex Therapeutics to present poster on its first antibody-drug conjugate product
- Social isolation and stress can raise breast cancer risk
- SAVI applicator for breast brachytherapy can be an effective therapy for breast cance
- Winner of the 2009 Outstanding Investigator Award for Breast Cancer Research
- Scientists attribute breast cancer decline to publicity surrounding WHI results
- Turmeric and pepper may play a role in preventing breast cancer
- Gene positions may offer a new method of cancer diagnosis
- Discovery may lead to new treatments for late-stage breast cancer
- Young women undergoing breast cancer screening may be exposed to unnecessary harm
- Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to an
- Consumer reports details the screening tests that may be unneccesary
- Soy food associated with lower risk of death and breast cancer recurrence, says new s
- Neoprobe completes Phase 3 Lymphoseek clinical trial on breast cancer patients
- Rise in cancer rates linked to excessive alcohol consumption
- Xanthohumol compound may aid in preventing prostate cancer
- Multiple clinical study results of ABRAXANE to be presented by Abraxis BioScience
- Social isolation and stress may increase susceptibility to breast cancer, finds US st
- Soy food beneficial for women with breast cancer
- Roche to present data on its Herceptin, Avastin and T-DM1 studies at the CTRC-AACR Sy
- Research study on breast cancer susceptibility in rats
- GPEC receives unrestricted grant of $250,000 to study new treatments for breast cance
- TECHGENE project: CLC bio selected as software partner
- Today's opinions and editorials
- German researchers study target-oriented methods for children with brain tumor
- Medifocus begins common stock trading on OTC Pink Sheets market
- Eli Lilly provides financial guidance for 2010
- Second-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals
- YM BioSciences announces results of collaborative antibody development program
- Merck commences Stimuvax Phase 3 trial in Asian patients with NSCLC
- Moderate consumption of alcoholic beverages increases the risk of breast cancer recur
- Soyfood consumption linked to decreased risk of breast cancer, finds study
- Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breas
- Women with high BMI are at increased risk of dying from breast cancer
- Initiation of multi-national Phase III study of Stimuvax announced
- Scientists develop new model of skin cancer based on Src kinases
- Positive results from Genomic Health's Oncotype DX study in breast cancer patients wi
- Combination of MRI and mammography screenings detects early-stage breast cancer
- Chemotherapy improves overall survival in postmenopausal breast cancer patients
- California's EWC program: Cuts alarm breast cancer survivors and advocates
- Stroke drug kills cancer cells and leaves normal cells intact, report researchers
- Proposed changes to breast cancer screening criticized
- African-American women in South Carolina more likely to have cervical cancer than whi
- New data suggests bisphosphonate drug may play a role in reducing recurrent breast ca
- Pfizer announces IES analysis of Aromasin in breast cancer recurrence
- Anti-estrogens may reduce the risk of death from lung cancer, according to study resu
- Results from clinical survey of Oncotype DX on patients with node-positive breast can
- Lapatinib plus trastuzumab extend lives of HER2-positive breast cancer patients
- Positive interim results of ARRY-380 in Phase 1 trial announced
- Positive Phase 2 study results of CDX-011 reported by Celldex Therapeutics
- ImmunoGen announces the presentation of positive trastuzumab-DM1 clinical data
- Study examines the association of BRCA1 gene, infertility and breast/ovarian cancer
- Incyte announces positive results from ongoing Phase I/II clinical trial for INCB7839
- Data from Phase 3 clinical evaluation of Lymphoseek presented
- New research highlights the benefit of shortened radiation course for patients with n
- Findings from three studies using bioTheranostics' breast cancer molecular test repor
- Texas researchers identify new detection method for circulating tumor cells
- Genentech announces positive results from Phase II study of T-DM1
- Combination of Herceptin and chemotherapy improves treatment for women with HER2+ bre
- Ipsen announces preliminary results of phase I trial in metastatic breast cancer with
- Black women with HR-positive breast cancer have worse disease-free and overall surviv
- Combination therapy improves overall survival in women with advanced breast cancer
- Results from Phase 2 trial evaluating Nexavar with capecitabine and paclitaxel presen
- Pfizer announces results from studies evaluating neratinib
- African American women with breast cancer receive no follow-up care after lumpectomy,
- Cell-enriched breast reconstruction procedure improves breast deformity in lumpectomy
- Additional therapy and screening may be needed for patients with mucinous breast canc
- New antibody-drug compound halts growth of metastatic breast tumors
- Study finds racial disparities in breast cancer care
- Researchers present new data for diagnosis and management of beast cancer
- Preclinical graft study supports Cytori’s proposed mechanism of action
- Breast Cancer Fund: It's time for the FDA to issue immediate ban on BPA in hard plast
- CTRC-AACR San Antonio Breast Cancer Symposium presents new data on emerging breast ca
- Hormone therapy: An important treatment option for post-menopausal women
- Genentech announces Phase III study of Avastin in women treated with chemotherapy for
- Medipattern and OMIC team up to provide breast ultrasound imaging service
- Updated clinical data from Phase 2 study evaluating oral ridaforolimus presented
- Women's health becomes political issue in health care debate
- Health experts discuss new treatment strategies for lung cancer at AACR-IASLC Joint C
- Study compares status of health care systems in U.S. and UK
- Health hazards of BPA: Call for FDA to make its announcement before Christmas
- NAMS recommends women to discuss osteoporosis with their OB/GYNs
- Cancer patients with dementia have lower survival rate than patients with cancer alon
- Nanoprobes deliver drugs directly to the right tumor cellular compartments
- Gamma Medica-Ideas signs exclusive license and commercialization agreement with Mayo
- University of Wisconsin IRB approves GenSpera's G-202 Phase I study for cancer
- Results from five new studies on Genomic Health's Oncotype DX breast cancer test anno
- Prostate cancer tests promised but not delivered
- Avastin may lose significant patient share to Sanofi-Aventis' BSI-201, according to r
- Reprints Desk signs distribution deals with seven STM journal publishers
- ODAC to review Cell Therapeutics' NDA for pixantrone
- Discovery of common single-letter variant in SNP links parental origin to risk of T2D
- Scientists discover possible way to identify malignant breast tumors without biopsy
- Reform issues in play: Selling insurance across state lines, Medicare’s doughnut hole
- RevMed MRI Technology converts standard grayscale scans to segmented, 3D, color image
- FDA clears Agendia's MammaPrint breast cancer recurrence test for all ages
- Scientists discover new model to asses homeostatic relationships between body substan
- Four commonly used chemotherapy drugs disrupt birth of new brain cells, shows study
- New statement on breast cancer by ACS underscores value of post-surgical radiation th
- Priority Health launches new line of wellness packages for companies
- BioMS Medical invests in Spectral Diagnostics to advance treatment for sepsis
- Malignant breast tumor detection without biopsy
- Possible link between presence of breast cancer genes and infertility discovered
- EMEA grants orphan drug designation for pixantrone in Europe
- Teva Pharmaceutical Industries, OncoGenex Pharmaceuticals announce collaboration in c
- Clarient announces acquisition of Applied Genomics
- Women eligible for breast cancer screening with MRI decline to undergo the procedure,
- New data shows more number of women are attending breast screening program
- Cell Therapeutics supports Code on Interactions with Healthcare Professionals
- Pharmadeal Financials database offers information on therapeutic license deals
- SenoRx wins patent infringement case
- Projects In Knowledge provides support for local, national, and global organizations
- Baylor University Medical Center adds Naviscan PEM to its imaging services
- Olive oil in prevention of breast cancer
- New project analyzes genetic sequence and variations of every gene expressed by 1,000
- Stochastic resonance can improve breast cancer detection
- New drug to stop cancer cells from growing and to stimulate immune system to destroy
- U.S. Congress approves $1.6 million for AdMeTech Foundation's research program
- Scientists use DNA sequence to characterize genome rearrangement in breast cancer sam
- Thyroid cancer on the rise
- CPF, ATS and health groups launch campaign to raise awareness on lung health
- Self-seeding process of cancer cells can enhance tumor growth, says study
- CGEN-671, a new drug target for multiple epithelial tumors discovered by Compugen
- Old Ideas Spur New Approaches in Cancer Fight
- apologize, but it is very Impprtant
- Results from Bionovo's study on BN107 published in the International Journal of Cance
- Acupuncture also improves sex drive while reducing hot flashes in breast cancer patie
- CPF reports success in advocacy, research support and awareness of PF
- Novartis Pharmaceuticals Canada named one of the top employers in Quebec
- Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic
- Sharing Miracles: A TV program that features inspirational stories of real patients
- WDI utilizes DXA analysis for fitness and weight management programs
- Yale: different groups of cells from same tumor presumably form tumors
- Scientists uncover an important link between inflammation and breast cancer stem cell
- EPO approves Advaxis patent application for Listeria Antigens
- AP series examines worldwide impact of drug resistance
- New campaign to provide retreats for women recovering from breast cancer launched
- Anti-aromatase phytochemicals in pomegranates reduce hormone-dependent breast cancer
- SBI and ACR publish new recommendations on breast cancer screening
- Formatech selects ViroMed’s VM206 for Fillanthropy Program
- Komen for the Cure organizes new fitness event to fight breast cancer
- Genetic rogue elements could help diagnose breast and bowel cancer
- RAD Technology Medical Systems announces breast cancer awareness campaign to support
- Findings reveals 'limpet-like' proteins can play a key role in DNA repair
- Multidisciplinary care, patient decision aids rarely offered by breast cancer surgeon
- Enzon Pharmaceuticals treats first patient in Phase 2 studies of PEG-SN38
- Phase II clinical trial results of Liposome-Entrapped Paclitaxel announced
- Study suggests pomegranates may prevent growth of breast cancer cells
- New guide reflects new breast cancer treatment options and authors' own personal expe
- BioVex's Phase 3 melanoma study amended to include first line patients
- FDA issues Fast Track Designation to Sopherion Therapeutics' Myocet
- Use of technology that expands access to qualified radiologist leads to earlier diagn
- Novelos Therapeutics to conclude pivotal Phase 3 trial in advanced non-small cell lun
- St. Andrews Country Club hosts 'Morgan & Friends Fight Cancer' Tournament to help fig
- Cancer Research UK scientists honorred for science and medical research
- Complete analysis of India's ultrasound systems market
- Sudden Cardiac Arrest Foundation announces first virtual affiliate of its National Su
- Variations in SNPs involved in modulating electrical impulse that govern working of h
- Institut Curie, Ipsogen sign scientific collaboration agreement in breast cancer doma
- Infinity Pharma: multiple drugs in trial
- Detroit paper explores pain of facing breast cancer without insurance
- More women die of breast cancer in areas where mammography centers are few
- YM BioSciences announces results of cancer antibody-radionuclide conjugate developmen
- Multigene test results impact physicians and patients' decisions on breast cancer the
- NetApp, Stanford Genome Technology Center build gastric cancer registry powered by Ne
- Yoga lowers number of compounds in blood and reduces inflammation
- Med-Vision implements Verisk Health’s Explorer solution to reduce clients' healthcare
- Mango effective against colon and breast cancers
- What's up guys?
- Scientists May Have Discovered Why Some Anticancer Agents Cause Heart Failure
- Life Technologies to acquire AcroMetrix
- Preliminary results from Nektar Therapeutics' NKTR-102 Phase 2 study in platinum-resi
vBulletin® v3.8.7, Copyright ©2000-2024, vBulletin Solutions, Inc.